Gillian Cannon

Director at Corcept Therapeutics · 5 reported transactions in 2 companies · latest trade Jun 5, 2026

Their trades


Xenon PharmaceuticalsXENE	Sold $63.2K · 1,190 shares	Jun 5, 2026	S&P 500 +3.8%thru Oct 27

Jun 5, 2026 · XENE

$63.2K

S&P 500 +3.8%thru Oct 27

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Corcept Therapeutics · 5 reported transactions in 2 companies · latest trade Jun 5, 2026


Xenon PharmaceuticalsXENE	Sold $63.2K · 1,190 shares	Jun 5, 2026	S&P 500 +3.8%thru Oct 27

Jun 5, 2026 · XENE

$63.2K

S&P 500 +3.8%thru Oct 27

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.